Last Updated: May 3, 2026

Annora Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ANNORA

ANNORA has sixty-one approved drugs.

There are eight tentative approvals on ANNORA drugs.

Summary for Annora
US Patents:0
Tradenames:52
Ingredients:52
NDAs:61
Patent Litigation for Annora: See patent lawsuits for Annora

Drugs and US Patents for Annora

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Annora Pharma MIRTAZAPINE mirtazapine TABLET;ORAL 219721-002 Oct 2, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma GABAPENTIN gabapentin SOLUTION;ORAL 217682-001 Jan 17, 2024 AA RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 219761-001 Mar 18, 2026 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma DARUNAVIR darunavir TABLET;ORAL 216168-002 Jan 21, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora DROXIDOPA droxidopa CAPSULE;ORAL 211726-001 Feb 18, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 212903-001 Oct 18, 2024 AA RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 218174-004 Aug 21, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.